Skip to main content
Aprogen Biologics Inc. logo

Aprogen Biologics Inc. — Investor Relations & Filings

Ticker · 003060 ISIN · KR7003060001 KO Manufacturing
Open in API
Filings indexed 383 across all filing types
Latest filing 2026-05-08 Director's Dealing
Country KR South Korea
Listing KO 003060

About Aprogen Biologics Inc.

https://www.aprogen.com/en/v.do?a=Main

Aprogen Biologics Inc. is a biopharmaceutical company focused on the development and manufacturing of antibody-based therapeutics. The company's activities encompass two main areas: the creation of novel biologics and the production of biosimilars. Its pipeline of new drugs includes candidates for treating conditions such as blood vessel diseases and tumors. Simultaneously, Aprogen develops a portfolio of biosimilar products to offer alternatives to existing biologic medicines. The company operates significant manufacturing facilities to support the production of its biopharmaceutical products for both clinical trials and commercial supply.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about securities ownership, changes in holdings, and related data for an individual named Kim Yong Woo, who is an executive. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange. This type of filing corresponds to notifications about insider or director share transactions or holdings. Given the content and purpose, this matches the definition of 'Director's Dealing' (DIRS). The document length is 2471 characters, which is consistent with a detailed insider transaction report rather than a brief announcement or a full financial report. Therefore, the classification is DIRS with high confidence.
2026-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about the ownership and changes in securities held by an executive or major shareholder, including dates, share counts, and ownership percentages. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal ownership disclosure. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document length is 2471 characters, which is consistent with a detailed ownership report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2026-05-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' which translates to 'Report on Large Holdings of Shares' and contains detailed information about shareholdings, changes in share ownership percentages, related contracts, and disclosures about major shareholders and their relationships. It includes specifics on share acquisition methods, contract details, and changes in ownership percentages. The document is regulatory in nature, reporting significant shareholding changes as required by capital market laws. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a meeting or voting results. This type of document corresponds to a Major Shareholding Notification, which is used to disclose changes in significant share ownership levels crossing regulatory thresholds.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about share ownership, changes in holdings, and related data for executives and major shareholders of the company (주)에이프로젠바이오로직스. The document includes dates, share counts, ownership percentages, and transaction details. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document length is 2625 characters, which is consistent with a detailed notification rather than a brief announcement or a full financial report. There is no indication of financial statements, audit information, or other report types. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2026-04-30 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 95% confidence The document is a "최대주주등소유주식변동신고서", which is a report filed to disclose changes in major shareholders’ ownership levels. This corresponds to a notification of significant shareholding changes (crossing thresholds) rather than an earnings release, management change, or other category. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2026-04-28 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 95% confidence The document is a voluntary disclosure providing details on the issuance results of a paid-in capital increase via third-party allotment (number of shares, amount raised, payment date), which is a share issue/capital change announcement. This matches the Share Issue/Capital Change category (SHA).
2026-04-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.